Dr. Falk PharmaFalk Foundation
  • About us
    About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence & business partners
  • Indications
    Indications
    • Autoimmune Hepatitis
    • Chronic Constipation
    • Colonoscopy
    • Crohn’s Disease
    • Eosinophilic Esophagitis
    • Hemorrhoidal disease
    • Irritable Bowel Syndrome
    • Microscopic Colitis
    • Primary Biliary Cholangitis
    • Ulcerative colitis
  • Our Products
  • Partnering
  • Newsroom
Search
Please choose your country
  • Global (English)
  • Australia
  • België (Vlaams)
  • Belgique (Français)
  • Deutschland
  • España
  • France
  • Ireland
  • Italia
  • Luxembourg (Français)
  • Nederland
  • Österreich
  • Portugal
  • Россия
  • Schweiz (Deutsch)
  • Suisse (Français)
  • United Kingdom
more info

Contact:
Phone:+49 0761 1514 0 Fax:+49 0761 1514 321 Email: zentrale@drfalkpharma.de

  • Falk Foundation
  • Contact us
  • Events
  • Reporting adverse events
  • Falsified medicines regulations
  • Imprint
  • Data Privacy
  • Social media guidelines
  • About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence & business partners
  • Indications
    • Autoimmune Hepatitis
    • Chronic Constipation
    • Colonoscopy
    • Crohn’s Disease
    • Eosinophilic Esophagitis
    • Hemorrhoidal disease
    • Irritable Bowel Syndrome
    • Microscopic Colitis
    • Primary Biliary Cholangitis
    • Ulcerative colitis
  • Our Products
  • Partnering
  • Newsroom
  • Falk Foundation
  • Contact us
  • Events
  • Reporting adverse events
  • Falsified medicines regulations
  • Imprint
  • Data Privacy
  • Social media guidelines
Contact:
Phone:
+49 0761 1514 0
Fax:
+49 0761 1514 321
Email:
zentrale[at]drfalkpharma.de
  • Homepage
  • Search

Search results

110 results

  • NEWSROOM
    Today is World IBD Day!
    Test your knowledge and learn more about IBD
  • NEWSROOM
    EoE Week 2023
    We support this year’s EoE Week in order to help raise awareness for eosinophilic esophagitis.
  • NEWSROOM
    Management change at Dr. Falk Pharma GmbH
    Kai Pinkernell takes over as Managing Director Science & Innovation.
  • NEWSROOM
    New Work in Freiburg
    Pilot space to find out which elements & spaces work for us
  • NEWSROOM
    Merry Christmas
    We wish you happy holidays and all the best for 2023
  • NEWSROOM
    3000 LinkedIn-Followers!
    Thank you very much! Together we know more. Together we do more.
  • NEWSROOM
    Rare Disease Day
    As the experts in digestive and metabolic medicine, our focus is also on rare diseases.
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • »
Falk Foundation

Discover the range of continuing education opportunities for physicians and pharmacists provided by the Falk Foundation e.V.

Dr. Falk Pharma GmbH

Dr. Falk Pharma is the expert in digestive and metabolic medicine. As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being. 

  • Falk Foundation
  • Events
  • Headquarters
  • Reporting adverse events
  • Falsified medicines regulations
  • Social media guidelines
© 2026 Dr. Falk Pharma GmbH
  • Imprint
  • Data Privacy
Notice

This website is an international information resource intended for healthcare professionals outside the United States (US) and United Kingdom (UK).

I am a health care professional outside the US and UK.

Accept
Notice
I confirm I am a UK or Irish resident and have been prescribed either Budenofalk®, Jorveza®, Salofalk® or Ursofalk®
Accept

You are leaving the website of Dr. Falk Pharma.

We are not liable for the accuracy of any content published on third party websites - such as the one you are about to be forwarded to.